InSite Vision Incorporated

InSite Vision Incorporated

InSite Vision Incorporated company was founded in 1986 and is based in Alameda, California. InSite Vision Incorporated operates as an ophthalmic product development company in the United States. It engages in the development and commercialization of ophthalmic pharmaceutical products based on DuraSite drug delivery technology. The company offers AzaSite for the treatment of bacterial conjunctivitis. It develops ISV-502, which completed Phase III (a) clinical trial for the treatment of blepharoconjunctivitis, an infection of the eyelid and the conjunctiva, as well as other ophthalmic infections; and ISV-405, a preclinical development candidate for the treatment of ocular infection. InSite Vision Incorporated has collaborative, licensing, and service agreements with Shin Poong Pharm Co., Ltd.; Bioceutica S.A.; Biem Pharmaceuticals; Essex Bio-Technology; Pfizer Inc. and Pfizer Products, Inc.; and Inspire Pharmaceuticals, Inc.; Catalent Pharma Solutions; and Bausch and Lomb Incorporated.

Contact Details

Office Address

InSite Vision Incorporated
965 Atlantic Avenue
Alameda, CA, USA 94501
Phone: (510) 865-8800
Fax: (510) 865-5700


Chief Exec. Officer, Chief Financial Officer and VP.

Mr. Louis C. Drapeau

VP of Devel.

Dr. Lyle M. Bowman

Business Reviews for InSite Vision Incorporated

Related Companies